Global Parasitic Diseases Therapeutics Market 2019-2023

寄生虫感染症治療法の世界市場:抗原虫性治療法、駆虫性治療法、殺かび及び殺真菌治療法

◆タイトル:Global Parasitic Diseases Therapeutics Market 2019-2023
◆商品コード:IRTNTR31466
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2019年6月19日
◆ページ数:125
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア太平洋、ヨーロッパ、中東・アフリカ、北米、南米
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥324,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

本調査レポートでは、寄生虫感染症治療法の世界市場について調べ、寄生虫感染症治療法の市場状況、市場規模、市場予測、市場環境、顧客状況、市場動向、関連企業情報などをまとめました。また、寄生虫感染症治療法の市場規模をセグメンテーション別(種類別(抗原虫性治療法、駆虫性治療法、殺かび及び殺真菌治療法))と地域別(グローバル、アジア太平洋、ヨーロッパ、中東・アフリカ、北米、南米)に分けて算出しました。
・サマリー
・レポートの範囲
・寄生虫感染症治療法の市場状況
・寄生虫感染症治療法の市場規模
・寄生虫感染症治療法の市場予測
・寄生虫感染症治療法の世界環境:ファイブフォース分析
・市場セグメンテーション:種類別(抗原虫性治療法、駆虫性治療法、殺かび及び殺真菌治療法)
・寄生虫感染症治療法の顧客状況
・主要地域別市場規模:グローバル、アジア太平洋、ヨーロッパ、中東・アフリカ、北米、南米
・意思決定フレームワーク
・市場動向・成長要因・課題
・関連企業状況・企業分析
 ...

Global Parasitic Diseases Therapeutics Market: About this market

Parasitic diseases include amebiasis, trichomoniasis, trypanosomiasis, giardiasis, African sleeping sickness, leishmaniasis, and malaria. Technavio’s parasitic diseases therapeutics market analysis considers sales of antiprotozoal therapeutics, anthelminthic therapeutics, and Scabicides and pediculicides therapeutics. Our analysis also considers the sales of parasitic diseases therapeutics in Asia, Europe, North America, and ROW. In 2018, the antiprotozoal therapeutics segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the high incidence of amebiasis in developing countries and industrialized countries will play a significant role in the antiprotozoal therapeutics segment to maintain its market position. Also, our global parasitic diseases therapeutics market report looks at factors such as the high prevalence of parasitic infections, approval of therapeutics to treat parasitic diseases, increased funding for R&D. However, challenges associated with antiparasitic drug discovery and diagnosing of disease, increasing drug resistance, and lack of effective therapies and side-effects of drugs may hamper the growth of the parasitic diseases therapeutics industry over the forecast period.

Global Parasitic Diseases Therapeutics Market: Overview

Rising prevalence of parasitic infections

There is an increase in the number of cases of people infected by whipworms and hookworms. Also, infections caused by ectoparasites, helminths, and protozoa is increasing. The incidence of schistosomiasis is also growing on a global level. This will drive the need for parasitic disease therapeutics and lead to the expansion of the global parasitic diseases therapeutics market at a CAGR of about 5% during the forecast period.

Increasing adoption of prophylactic treatment

Researchers around the world are increasingly focusing on the development of vaccines due to the high prevalence of malaria. Diseases such as visceral leishmaniasis and cutaneous leishmaniasis can be prevented with the help of prophylactic vaccines. The development and consumption of such vaccines help in controlling parasitic diseases. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global parasitic diseases therapeutics market during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of several major players, the global parasitic diseases therapeutics market is fragmented. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading parasitic diseases therapeutics manufacturers, that include Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Pfizer Inc., and Sanaria Inc.

Also, the parasitic diseases therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

【資料の目次】

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

2.1 Preface

2.2 Preface

2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: MARKET SEGMENTATION BY TYPE

Market segmentation by type

Comparison by type

Antiprotozoal therapeutics – Market size and forecast 2018-2023

Anthelminthic therapeutics – Market size and forecast 2018-2023

Scabicides and pediculicides therapeutics – Market size and forecast

2018-2023

Market opportunity by type

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

Asia – Market size and forecast 2018-2023

ROW – Market size and forecast 2018-2023

North America – Market size and forecast 2018-2023

Europe – Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 11: MARKET TRENDS

Favorable drug pipeline

Increasing initiatives to eliminate parasitic diseases

Increasing adoption of prophylactic treatment

PART 12: VENDOR LANDSCAPE

Overview

Landscape disruption

PART 13: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

Bayer AG

F. Hoffmann-La Roche Ltd.

GlaxoSmithKline Plc

Pfizer Inc.

Sanaria Inc.

PART 14: APPENDIX

Research methodology

List of abbreviations

Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

Exhibit 01: Global infectious disease treatment market

Exhibit 02: Segments of global infectious disease treatment market

Exhibit 03: Market characteristics

Exhibit 04: Market segments

Exhibit 05: Drugs used to treat various parasitic diseases

Exhibit 06: Market definition – Inclusions and exclusions checklist

Exhibit 07: Market size 2018

Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)

Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)

Exhibit 10: Five forces analysis 2018

Exhibit 11: Five forces analysis 2023

Exhibit 12: Bargaining power of buyers

Exhibit 13: Bargaining power of suppliers

Exhibit 14: Threat of new entrants

Exhibit 15: Threat of substitutes

Exhibit 16: Threat of rivalry

Exhibit 17: Market condition – Five forces 2018

Exhibit 18: Type – Market share 2018-2023 (%)

Exhibit 19: Comparison by type

Exhibit 20: Antiprotozoal therapeutics – Market size and forecast 2018-2023 ($ millions)

Exhibit 21: Antiprotozoal therapeutics – Year-over-year growth 2019-2023 (%)

Exhibit 22: Anthelminthic therapeutics – Market size and forecast 2018-2023 ($ millions)

Exhibit 23: Anthelminthic therapeutics – Year-over-year growth 2019-2023 (%)

Exhibit 24: Scabicides and pediculicides therapeutics – Market size and forecast 2018-2023 ($ millions)

Exhibit 25: Scabicides and pediculicides therapeutics – Year-over-year growth 2019-2023 (%)

Exhibit 26: Market opportunity by type

Exhibit 27: Customer landscape

Exhibit 28: Market share by geography 2018-2023 (%)

Exhibit 29: Geographic comparison

Exhibit 30: Asia – Market size and forecast 2018-2023 ($ millions)

Exhibit 31: Asia – Year-over-year growth 2019-2023 (%)

Exhibit 32: ROW – Market size and forecast 2018-2023 ($ millions)

Exhibit 33: ROW – Year-over-year growth 2019-2023 (%)

Exhibit 34: North America – Market size and forecast 2018-2023 ($ millions)

Exhibit 35: North America – Year-over-year growth 2019-2023 (%)

Exhibit 36: Europe – Market size and forecast 2018-2023 ($ millions)

Exhibit 37: Europe – Year-over-year growth 2019-2023 (%)

Exhibit 38: Key leading countries

Exhibit 39: Market opportunity

Exhibit 40: Impact of drivers and challenges

Exhibit 41: Drug candidates under development

Exhibit 42: Vendor landscape

Exhibit 43: Landscape disruption

Exhibit 44: Vendors covered

Exhibit 45: Vendor classification

Exhibit 46: Market positioning of vendors

Exhibit 47: Bayer AG – Vendor overview

Exhibit 48: Bayer AG – Business segments

Exhibit 49: Bayer AG – Organizational developments

Exhibit 50: Bayer AG – Geographic focus

Exhibit 51: Bayer AG – Segment focus

Exhibit 52: Bayer AG – Key offerings

Exhibit 53: F. Hoffmann-La Roche Ltd. – Vendor overview

Exhibit 54: F. Hoffmann-La Roche Ltd. – Business segments

Exhibit 55: F. Hoffmann-La Roche Ltd. – Organizational developments

Exhibit 56: F. Hoffmann-La Roche Ltd. – Geographic focus

Exhibit 57: F. Hoffmann-La Roche Ltd. – Segment focus

Exhibit 58: F. Hoffmann-La Roche Ltd. – Key offerings

Exhibit 59: GlaxoSmithKline Plc – Vendor overview

Exhibit 60: GlaxoSmithKline Plc – Business segments

Exhibit 61: GlaxoSmithKline Plc – Organizational developments

Exhibit 62: GlaxoSmithKline Plc – Geographic focus

Exhibit 63: GlaxoSmithKline Plc – Segment focus

Exhibit 64: GlaxoSmithKline Plc – Key offerings

Exhibit 65: Pfizer Inc. – Vendor overview

Exhibit 66: Pfizer Inc. – Business segments

Exhibit 67: Pfizer Inc. – Organizational developments

Exhibit 68: Pfizer Inc. – Geographic focus

Exhibit 69: Pfizer Inc. – Segment focus

Exhibit 70: Pfizer Inc. – Key offerings

Exhibit 71: Sanaria Inc. – Vendor overview

Exhibit 72: Sanaria Inc. – Key offerings

Exhibit 73: Validation techniques employed for market sizing

Exhibit 74: Definition of market positioning of vendors



【掲載企業】

Bayer AG、F. Hoffmann-La Roche Ltd.、GlaxoSmithKline Plc、Pfizer Inc.、Sanaria Inc.

★調査レポート[寄生虫感染症治療法の世界市場:抗原虫性治療法、駆虫性治療法、殺かび及び殺真菌治療法] (Global Parasitic Diseases Therapeutics Market 2019-2023 / IRTNTR31466)販売に関する免責事項
[寄生虫感染症治療法の世界市場:抗原虫性治療法、駆虫性治療法、殺かび及び殺真菌治療法] (Global Parasitic Diseases Therapeutics Market 2019-2023 / IRTNTR31466)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆